Targeted Cancer Therapy: Small Molecule Drugs Flashcards
Erlotinib Mechanism
EGFR: TK-Inhibitor
compete with ATP for binding site on EGFR-TK cytosolic domain
Erlotinib Use
Non-small Cell Lung cancer
Erlotinib Side Effects
Rash
Diarrhea
Fatigue
Gefitinib Mechanism
EGFR: TK-Inhibitor
compete with ATP for binding site on EGFR-TK cytosolic domain
Gefitinib use
Non-small Cell Lung cancer
Gefinitib Side Effects
Rash
Diarrhea
Fatigue
Afatinib Mechanism
EGFR: TK-Inhibitor
compete with ATP for binding site on EGFR-TK cytosolic domain
Afatinib use
Non-small Cell Lung cancer
Afatinib Side effects
Rash
Diarrhea
Fatigue
Alectinib Mechanism
Inhibit TK-R targeting ALK
Alectinib Use
Metastatic Non-small cell lung cancer
Alectinib Side Effects
Edema
Rash
Diarrhea
Crizotinib Mechanism
Inhibit TK-R targeting ALK
Crizotinib Use
Metastatic Non-small cell lung cancer
Crizotinib Side Effects
Edema
Rash
Diarrhea
Imatinib Mechanism
TK inhibitor of BCR-ABL fusion protein and C-Kit